NCT00527033View on ClinicalTrials.gov

A Study of YM178 in Patients With Symptomatic Overactive Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

842

Participants

Timeline

Start Date

September 11, 2007

Primary Completion Date

April 3, 2008

Study Completion Date

April 3, 2008

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

YM178

Oral

DRUG

Placebo

Oral

Trial Locations (5)

Unknown

Chūbu

Hokkaido

Kansai

Kanto

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY